Phathom Pharmaceuticals, Inc. - Common Stock (PHAT)

Historical Holders from Q4 2019 to Q3 2025

Symbol
PHAT on Nasdaq
CUSIP
71722W107
Type / Class
Equity / Common Stock
Shares outstanding
71.4M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
57.4M
Holdings value
$551M
% of all portfolios
0.003%
Grand Portfolio weight change
0%
Number of holders
117
Number of buys
59
Number of sells
-73
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Phathom Pharmaceuticals, Inc. - Common Stock (PHAT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Frazier Life Sciences Public Fund, L.P. 8.6% -56.5% $74.5M -$105M 5.99M -58.5% James N. Topper Aug 18, 2025
MILLENNIUM MANAGEMENT LLC 5.9% +12% $51.8M $4.96M 4.16M +10.6% Millennium Management LLC Aug 19, 2025
Carlyle Group Inc. 4.9% $43.5M 3.5M Carlyle Group Inc. Aug 28, 2025
BlackRock, Inc. 4.6% $15.7M 3.23M BlackRock, Inc. Mar 31, 2025
PRUDENTIAL FINANCIAL INC 0% -100% $8.71K -$24.5M 2.63K -100% PRUDENTIAL FINANCIAL INC May 31, 2025

Institutional Holders of Phathom Pharmaceuticals, Inc. - Common Stock (PHAT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 59.2K $939K +$195K $12.03 4
2025 Q2 57.4M $551M -$26.7M $9.59 117
2025 Q1 64M $401M -$24.9M $6.27 136
2024 Q4 66.6M $541M -$122M $8.12 140
2024 Q3 72.6M $1.31B +$264M $18.08 133
2024 Q2 56.6M $583M +$44.3M $10.30 113
2024 Q1 55.4M $588M +$13.7M $10.62 112
2023 Q4 7.47M $77.5M $9.75 2
2023 Q3 43.8M $453M +$5.27M $10.37 110
2023 Q2 42.8M $613M +$176M $14.32 103
2023 Q1 30.8M $220M +$28.3M $7.14 82
2022 Q4 28.2M $317M -$21.7M $11.22 83
2022 Q3 30.1M $333M +$38.5M $11.08 85
2022 Q2 26.9M $227M +$9.1M $8.44 81
2022 Q1 25.6M $348M -$61.3M $13.61 73
2021 Q4 28.4M $559M +$47.8M $19.67 78
2021 Q3 25.4M $817M +$19.1M $32.10 79
2021 Q2 24.9M $841M +$13.2M $33.85 75
2021 Q1 24.5M $919M +$1.76M $37.56 83
2020 Q4 24.5M $815M +$96.3M $33.22 75
2020 Q3 21.6M $794M -$7.64M $36.67 56
2020 Q2 21.8M $719M -$3.05M $32.91 59
2020 Q1 21.9M $566M +$3.22M $25.82 45
2019 Q4 21.8M $677M +$593M $31.14 40